Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin

dc.contributor.authorBalik, Ahmet Yildirim
dc.contributor.authorEdiz, Emre
dc.contributor.authorAyvacik, Burak
dc.contributor.authorTaskiran, Arda Taskin
dc.contributor.authorBasaran, Ekrem
dc.contributor.authorBaba, Dursun
dc.date.accessioned2026-07-01T11:39:44Z
dc.date.available2026-07-01T11:39:44Z
dc.date.issued2026
dc.departmentDüzce Üniversitesi
dc.description.abstractObjectives To compare the effectiveness and safety of two antibiotic prophylaxis regimens, ciprofloxacin plus gentamicin and ceftriaxone plus cefixime, in preventing infectious complications after transrectal ultrasound-guided prostate biopsy.Methods The study retrospectively reviewed 705 consecutive patients who underwent transrectal ultrasound-guided prostate biopsy between January 2020 and January 2024. Group 1 (n = 374) received ciprofloxacin plus gentamicin, and Group 2 (n = 331) received ceftriaxone plus cefixime. All patients underwent standard rectal preparation with povidone-iodine, and needle-tip disinfection with formalin. The primary outcome was the development of post-biopsy infectious complications, while secondary outcomes included sepsis and infection-related hospitalization.Results The two groups were comparable in terms of age, body mass index, prostate-specific antigen levels, and comorbidities. The overall rate of post-biopsy infection was 1.4%, occurring in 1.1% patients in Group 1 and 1.8% patients in Group 2 (p = 0.61). The incidence of complicated urinary tract infection was 0.3% versus 0.9%, and infection-related hospitalization occurred in 0.5% versus 0.3% of patients in Group 1 and Group 2, respectively, with no cases of sepsis observed. In univariable analyses, diabetes mellitus, histopathological chronic prostatitis, and pre-biopsy antibiotic use were not significantly associated with post-biopsy infection.Conclusion The combination of ceftriaxone and cefixime showed a safety profile broadly consistent with the combination of ciprofloxacin and gentamicin for biopsy prophylaxis. Considering increasing fluoroquinolone resistance and growing restrictions, this cephalosporin-based regimen may be considered a feasible option for transrectal ultrasound-guided prostate biopsy when implemented together with strict antiseptic measures.
dc.identifier.doi10.1111/iju.70445
dc.identifier.issn0919-8172
dc.identifier.issn1442-2042
dc.identifier.issue4
dc.identifier.pmid41891504
dc.identifier.scopus2-s2.0-105034117436
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1111/iju.70445
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23450
dc.identifier.volume33
dc.identifier.wosWOS:001748549000005
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofInternational Journal of Urology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260623
dc.subject[Keyword Not Available]
dc.titleComparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin
dc.typeArticle

Dosyalar